HENRY JOHN BAKER
Pilots at Creekwood Trl, Auburn, AL
License number
Alabama A0077071
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
1804 Creekwood Trl, Auburn, AL 36830
Professional information
Peptides For Recognition And Targeting Of Glial Cell Tumors
US Patent:
7094868, Aug 22, 2006
Filed:
Feb 4, 2003
Appl. No.:
10/357929
Inventors:
Tatiana I. Samoylova - Auburn AL, US
Valery A. Petrenko - Auburn AL, US
Nancy R. Cox - Auburn AL, US
Nancy E. Morrison - Auburn AL, US
Henry J. Baker - Auburn AL, US
Ludmila P. Globa - Auburn AL, US
Valery A. Petrenko - Auburn AL, US
Nancy R. Cox - Auburn AL, US
Nancy E. Morrison - Auburn AL, US
Henry J. Baker - Auburn AL, US
Ludmila P. Globa - Auburn AL, US
Assignee:
Auburn University - Auburn AL
International Classification:
C07K 7/04, C07K 7/06, C07K 5/00, C07K 17/00, C12Q 1/70, G01N 33/574, C12N 7/01, C12N 15/00
US Classification:
530328, 530300, 530329, 530330, 530333, 435 5, 435 723, 4352351, 4353201
Abstract:
Compositions for use in characterization, diagnosis, prognosis, and therapy of cancer cells are provided. The compositions comprise peptides and variants thereof which were isolated based on their ability to selectively bind glioma cells.
Professor At Auburn University
Position:
Professor at Auburn University
Location:
Auburn, Alabama Area
Industry:
Higher Education
Work:
Auburn University
-
Professor
Nucleic Acid Vaccination For Parvoviral Infections
US Patent:
6465438, Oct 15, 2002
Filed:
Oct 19, 1998
Appl. No.:
09/171425
Inventors:
Joachim Schorr - Hilden, DE
Henry J. Baker - Auburn AL
Bruce F. Smith - Auburn AL
Henry J. Baker - Auburn AL
Bruce F. Smith - Auburn AL
Assignee:
Metin Colpan - Essen
International Classification:
A61K 4800
US Classification:
514 44, 424 931, 4353201
Abstract:
The general field of the invention is a method for nucleic acid vaccination for animals to protect them from parvoviral infection. This invention is more particularly related to the preparation and use of parvoviral DNA and its administration to dogs, cats and mink so as to induce an immune response that can protect these animals from disease caused by virulante parvovirus. Nucleic acid immunogens are designed to include the antigenic portions of the parvoviral genome which are incorporated into bacterial plasmids. These plasmids produce the desired parvoviral gene product when introduced into host cells by transfection. Host cells transfected with the parvoviral immunogen expressing plasmids produce a stream ot antigenic proteins to which the host immune system will mount a protective immune response.
Methods And Compositions For Targeting Compounds To The Central Nervous System
US Patent:
6399575, Jun 4, 2002
Filed:
Nov 10, 1999
Appl. No.:
09/438150
Inventors:
Bruce F. Smith - Auburn AL
Tatiana I. Samoilova - Auburn AL
Henry J. Baker - Auburn AL
Tatiana I. Samoilova - Auburn AL
Henry J. Baker - Auburn AL
Assignee:
Auburn University - Auburn AL
International Classification:
A61K 3808
US Classification:
514 16, 530329
Abstract:
Compositions for use in targeting therapies to central nervous system (CNS) cells are provided. The compositions comprise peptides which are capable of binding CNS cells in vivo.
Methods For Targeting And Killing Glioma Cells
US Patent:
7642063, Jan 5, 2010
Filed:
May 19, 2005
Appl. No.:
11/132879
Inventors:
Tatiana I. Samoylova - Auburn AL, US
Henry J. Baker - Auburn AL, US
Nancy R. Cox - Auburn AL, US
Ludmila P. Globa - Auburn AL, US
Nancy E. Morrison - Auburn AL, US
Henry J. Baker - Auburn AL, US
Nancy R. Cox - Auburn AL, US
Ludmila P. Globa - Auburn AL, US
Nancy E. Morrison - Auburn AL, US
Assignee:
Auburn University - Auburn AL
International Classification:
A61K 38/17, A61K 51/00, G01N 33/574
US Classification:
435 723, 424 149, 514 2
Abstract:
A diagnostic technique for matching anti-cancer peptide drugs to the molecular profiles of individual cancer tumors, and a method using the technique for a patient-specific treatment of tumors in mammals. This strategy matches anti-cancer peptide drugs to the molecular profiles of individual tumors, and includes the development of two banks, both of which use the same targeting peptides. Targeting peptides are identified using biopsies or other tissue materials from multiple cancer patients and placed into two banks. For a bank of probes, targeting peptides are linked to a label such as a fluorescent or a radioisotope. For a bank of drugs, targeting peptides are linked to a cytotoxic peptide to form a “targeting peptide drug”. Peptide probes are used to establish molecular profiles of individual tumors. Based on these molecular profiles, a patient-specific combination of targeting drugs from the bank of peptide drugs is prepared and the patient is treated.
Methods Of Identifying Peptides And Compositions That Bind To Oocytes In A Species-Specific Manner
US Patent:
8158366, Apr 17, 2012
Filed:
Apr 7, 2009
Appl. No.:
12/419883
Inventors:
Tatiana I. Samoylova - Auburn AL, US
Henry J. Baker - Auburn AL, US
Nancy Cox - Auburn AL, US
Stephen Ditchkoff - Auburn AL, US
Henry J. Baker - Auburn AL, US
Nancy Cox - Auburn AL, US
Stephen Ditchkoff - Auburn AL, US
Assignee:
Auburn University - Auburn AL
International Classification:
G01N 33/53
US Classification:
435 71, 4241401, 424811, 435413, 435853
Abstract:
Disclosed are methods of identifying peptides and compositions that bind to oocytes of animals in a species-specific manner. The methods utilize phage libraries and oocytes isolated from target species and non-target species.
Methods For Identifying Peptides That Bind To Intact Oocytes
US Patent:
8057992, Nov 15, 2011
Filed:
Nov 7, 2008
Appl. No.:
12/266944
Inventors:
Tatiana I. Samoylova - Auburn AL, US
Henry J. Baker - Auburn AL, US
Brenda Griffin - Ithaca NY, US
Kristina Pendergrass - Tallassee AL, US
Ludmila P. Globa - Auburn AL, US
M. Daniel Givens - Auburn AL, US
Kay P. Riddell - Auburn AL, US
Nancy Cox - Auburn AL, US
Henry J. Baker - Auburn AL, US
Brenda Griffin - Ithaca NY, US
Kristina Pendergrass - Tallassee AL, US
Ludmila P. Globa - Auburn AL, US
M. Daniel Givens - Auburn AL, US
Kay P. Riddell - Auburn AL, US
Nancy Cox - Auburn AL, US
Assignee:
Auburn University - Auburn AL
International Classification:
G01N 33/53
US Classification:
435 5, 435 71, 435 72, 435 721, 436510, 530853, 424561, 424811
Abstract:
Disclosed are methods, compositions, and zona pellucida binding peptides and polypeptides for use in immunocontraception of canines and other animals. The disclosed compositions may include pharmaceutical compositions. Methods for identifying peptides that bind to intact oocytes also are provided, in particular methods for identifying peptides that bind to zona pellucida of intact oocytes.
Zona Pellucida Binding Peptides For Species Specific Immunocontraception Of Animals
US Patent:
8492516, Jul 23, 2013
Filed:
Mar 9, 2012
Appl. No.:
13/416348
Inventors:
Tatiana I. Samoylova - Auburn AL, US
Henry J. Baker - Auburn AL, US
Nancy Cox - Auburn AL, US
Stephen Ditchkoff - Auburn AL, US
Kent Van Kampen - Hoover AL, US
Henry J. Baker - Auburn AL, US
Nancy Cox - Auburn AL, US
Stephen Ditchkoff - Auburn AL, US
Kent Van Kampen - Hoover AL, US
Assignee:
Auburn University - Auburn AL
International Classification:
C07K 5/00
US Classification:
530327, 4241391, 4241841, 4241851, 424811, 514 98
Abstract:
Disclosed are methods, compositions, zona pellucida binding peptides and polypeptides, and expression vectors for use in species-specific immunocontraception of animals. The disclosed compositions may include immunogenic compositions or vaccines.
Zona Pellucida Binding Peptides, Expression Vectors, Compositions, And Methods For Species-Specific Immunocontraception Of Animals
US Patent:
2014003, Jan 30, 2014
Filed:
Jul 23, 2013
Appl. No.:
13/948808
Inventors:
Henry J. Baker - Auburn AL, US
Nancy Cox - Auburn AL, US
Stephen Ditchkoff - Auburn AL, US
Kent Van Kampen - Hoover AL, US
Nancy Cox - Auburn AL, US
Stephen Ditchkoff - Auburn AL, US
Kent Van Kampen - Hoover AL, US
International Classification:
C07K 7/08, G01N 33/53
US Classification:
4241851, 506 9, 530327, 536 231, 4353201, 4353171, 435 691
Abstract:
Disclosed are methods, compositions, zona pellucida binding peptides and polypeptides, and expression vectors for use in species-specific immunocontraception of animals. The disclosed compositions may include immunogenic compositions or vaccines.